Please assess the completion status of the following clinical trial:

Trial Title: Dexmedetomidine Sedation Versus General Anaesthesia for Inguinal Hernia Surgery in Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants below 3 months of age ( corrected age 54 weeks) presenting for elective inguinal hernia repair in KKH.~Exclusion Criteria:~* History of prematurity younger than 28 weeks gestation,~* Requirement for CPAP greater than 6 cmH20 at time of surgery~* Significant cardiac pathology or cardiac conduction defects~* Unusually large hernia sacs~* Any contraindication for caudal anesthesia~* Surgeon refusal on account of anticipated prolonged or difficult surgery.

- Gender: ALL
- Minimum Age: 34 Weeks
- Maximum Age: 54 Weeks
- Healthy Volunteers: t

Study Arms:
- Dex Group (Type: EXPERIMENTAL): Intravenous dexmedetomidine sedation prior to single shot caudal anaesthesia and maintenance infusion of dexmedetomidine during bilateral inguinal hernia surgery.
- GA Group (Type: ACTIVE_COMPARATOR): General sevoflurane anaesthesia with endotracheal intubation and single shot caudal anaesthesia for inguinal hernia surgery. This is currently the standard anaesthetic technique for bilateral inguinal hernia surgery in neonates and infants in KKH.

Based on this trial design, predict the completion outcome and termination type (if applicable).